Association between systemic lupus erythematosus and Helicobacter Pylori [4]

Journal of Rheumatology

Volumn 32, Issue 5, 2005, Pages 965-

  Matsukawa, Yoshihiro ^a  

^a Department of Plastic and Reconstructive Surgery   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON RECEPTOR; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 65; INTERLEUKIN 2 RECEPTOR ALPHA;

ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; BACTERIAL COLONIZATION; DISEASE ACTIVITY; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 18744397225     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Sawalha AH, Schmid WR, Binder SR, Bacino DK, Harley JB. Association between systemic lupus erythematosus and Helicobacter pylori seronegativity. J Rheumatol 2004;31:1546-50.
2. Zentilin P, Seriolo B, Dulbecco P, et al. Eradication of Helicobacter pylori may reduce disease activity in rheumatoid arthritis. Aliment Pharmacol Ther 2002;16:1291-9.
3. Gomez D, Correa PA, Gomez LM, Cadena J, Molina JF, Anaya JM. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective? Semin Arthritis Rheum 2003;33:404-13.
4. Amit M, Mor A, Weissgarten J, et al. Inactive systemic lupus erythematosus is associated with a normal stimulated Th(1)/Th(2) cytokine secretory pattern. Cytokine 2000;12:405-8.
5. Chen S, Hu D, Shi X, Shen N, Gu Y, Bao C. The relationship between Th1/Tb2-type cells and disease activity in patients with systemic lupus erythematosus. Chin Med J 2000;113:877-80.
6. Kalabay L, Fekete B, Czirjak L, et al. Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to Mycobacterial hsp65 but not to human hsp60. Helicobacter 2002;7:250-6.
7. Lai NS, Lan JL, Yu CL, et al. A dominant human leucocyte antigen DR4-Dw1 5 restricted mycobacterial 65kDa antigen-specific T-cell immunity in Chinese patients with rheumatoid arthritis. Br J Rheumatol 1995;34:498-506.
8. Prohaszka Z, Duba J, Lakos G, et al. Antibodies against human heat-shock protein (hsp) 60 and mycobacterial hsp65 differ in their antigen specificity and complement-activating ability. Int Immunol 1999;11:1363-70.
9. Cobelens PM, Heijnen CJ, Nieuwenhuis EE, et al. Treatment of adjuvant-induced arthritis by oral administration of mycobacterial Hsp65 during disease. Arthritis Rheum 2000;43:2694-702.
10. Matsukawa Y, Asai Y, Kitamura N, Sawada S, Kurosaka H. Exacerbation of rheumatoid arthritis following Helicobacter pylori eradication: disruption of established oral tolerance against heat shock protein? Med Hypotheses 2005;64:41-3.